Published in Acta Neurol Scand on June 01, 1979
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc Natl Acad Sci U S A (2007) 1.19
Immunoglobulin G heavy chain (Gm) allotypes in multiple sclerosis. J Clin Invest (1981) 1.04
HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry (2002) 0.98
B cells as a target of immune modulation. Ann Indian Acad Neurol (2009) 0.76
Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group. J Neurol Neurosurg Psychiatry (1988) 0.75
Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity. J Clin Invest (1986) 0.75
STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output. J Clin Invest (1928) 45.56
STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46
Two distinct subtypes of human respiratory syncytial virus. J Gen Virol (1985) 5.19
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler (1999) 4.91
Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest (1977) 4.63
COBAS AMPLICOR: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR. Clin Chem (1996) 3.17
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc Natl Acad Sci U S A (1992) 2.98
Presence of haemagglutinin in the envelope of extracellular vaccinia virus particles. J Gen Virol (1976) 2.78
Differences in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J Infect Dis (1975) 2.54
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch Neurol (1971) 2.51
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
Respiratory syncytial virus envelope glycoprotein (G) has a novel structure. Nucleic Acids Res (1985) 2.37
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28
The structural and functional diversity of Adenovirus capsid components. J Gen Virol (1969) 2.14
Structural polypeptides of measles virus. J Gen Virol (1978) 2.11
Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1973) 2.10
Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09
Appearance and persistence of antibodies against different virus components after regular measles infections. Infect Immun (1972) 2.08
Adsorption and penetration of enveloped and naked vaccinia virus particles. J Virol (1978) 2.06
Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet (1996) 2.06
Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections. J Clin Microbiol (1987) 2.06
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med (1988) 2.04
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer. Eur J Cancer (2004) 2.03
Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest (1977) 2.02
Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun (1975) 2.01
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer (2006) 1.96
Monoclonal antibodies against five structural components of measles virus. I. Characterization of antigenic determinants on nine strains of measles virus. Virology (1983) 1.85
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis. Infect Immun (1972) 1.82
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
Occurrence of respiratory syncytial virus subtypes A and B strains in Sweden. J Med Virol (1986) 1.81
Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain (2001) 1.78
Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology (1991) 1.77
[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74
Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B. J Gen Virol (1987) 1.73
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett (1991) 1.73
Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest (2001) 1.70
Respiratory syncytial virus fusion glycoprotein: nucleotide sequence of mRNA, identification of cleavage activation site and amino acid sequence of N-terminus of F1 subunit. Nucleic Acids Res (1985) 1.69
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis. Scand J Immunol (1976) 1.66
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol (1991) 1.65
Neutralizing and binding anti-interferon-beta (IFN-beta) antibodies. A comparison between IFN-beta-1a and IFN-beta-1b treatment in multiple sclerosis. Eur J Neurol (2000) 1.61
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
Chromosome damage associated with the measles virus in vitro. Hereditas (1965) 1.60
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58
Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986. J Infect Dis (1988) 1.58
Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest (1990) 1.57
HL-A antigens in sarcoidosis. Tissue Antigens (1973) 1.55
Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus. Proc Natl Acad Sci U S A (1987) 1.55
Early diagnosis of tuberculous meningitis by detection of anti-BCG secreting cells in cerebrospinal fluid. Lancet (1990) 1.55
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Morphogenesis of respiratory syncytial virus in a green monkey kidney cell line (Vero). J Virol (1970) 1.53
Increased incidence of Guillain-Barré syndrome postpartum. Epidemiology (1998) 1.53
Structural components of measles virus. Microbios (1972) 1.51
Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells. Arch Virol (1982) 1.50
Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus. J Gen Virol (1988) 1.50
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1alpha attenuates neutrophil recruitment in the central nervous system during experimental bacterial meningitis. Infect Immun (1999) 1.48
Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun (1974) 1.48
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
Altered surface marker expression and function of G-CSF-induced neutrophils from test subjects and patients under chemotherapy. Br J Haematol (1994) 1.45
Structural differences between subtype A and B strains of respiratory syncytial virus. J Gen Virol (1986) 1.45
Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group. Blood (1993) 1.45
Measles virus antibodies in multiple sclerosis. Comparison of antibody titers in cerebrospinal fluid and serum. Arch Neurol (1974) 1.44
Cytokine autoantibodies in multiple sclerosis, aseptic meningitis and stroke. Eur J Clin Invest (1998) 1.44
The B cell repertoire in experimental allergic neuritis involves multiple myelin proteins and GM1. J Neurol Sci (1994) 1.43
Paramyxovirus SV5 and multiple sclerosis. Nature (1989) 1.43
A carrier cell line of measles virus in Lu 106 cells. Arch Gesamte Virusforsch (1967) 1.41
Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat Immunol (2000) 1.40
Splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia. Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Br J Haematol (1996) 1.40
Immunological relationships between homologous structural polypeptides of measles and canine distemper virus. J Gen Virol (1980) 1.40
Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: exacerbations and remissions. Arch Neurol (1973) 1.40
Immunologic properties of purified Sendai virus glycoproteins. J Immunol (1977) 1.39
The effect of a carbobenzoxy tripeptide on the biological activities of measles virus. Virology (1971) 1.38
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. Br J Haematol (2000) 1.37
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol (1991) 1.36
The relationship between the soluble antigens and the virion of adenovirus type 3. I. Morphological characteristics. Virology (1966) 1.36
Antigen binding cells in tolerant animals. Nature (1970) 1.35
Immunoglobulins and measles antibodies in subacute sclerosing panencephalitis. Arch Neurol (1973) 1.35
Persistence of RNA viruses in the central nervous system. Annu Rev Microbiol (1986) 1.33
Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Ann Neurol (1994) 1.33
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Serum antibody responses to individual viral polypeptides in human rotavirus infections. J Gen Virol (1987) 1.31
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group. Leukemia (2000) 1.31
Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res (1996) 1.30
Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis. J Immunol (2001) 1.30
Cerebrospinal fluid and serum immunoglobulins and antibody titers in mumps meningitis and aseptic meningitis of other etiology. Infect Immun (1978) 1.28